Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 5,990.00
+40.00 (0.67%)
At close: Jun 27, 2025, 3:30 PM KST
Kyung Dong Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 194,663 | 193,936 | 162,674 | 182,718 | 177,611 | 173,828 | Upgrade
|
| Other Revenue | -0 | -0 | - | -0 | - | - | Upgrade
|
| Revenue | 194,663 | 193,936 | 162,674 | 182,718 | 177,611 | 173,828 | Upgrade
|
| Revenue Growth (YoY) | 14.35% | 19.22% | -10.97% | 2.88% | 2.18% | -1.51% | Upgrade
|
| Cost of Revenue | 78,649 | 79,571 | 73,331 | 86,808 | 79,528 | 74,560 | Upgrade
|
| Gross Profit | 116,015 | 114,365 | 89,344 | 95,910 | 98,082 | 99,268 | Upgrade
|
| Selling, General & Admin | 99,996 | 98,621 | 86,471 | 70,602 | 68,447 | 67,295 | Upgrade
|
| Research & Development | 9,159 | 11,120 | 13,827 | 12,618 | 10,537 | 10,063 | Upgrade
|
| Other Operating Expenses | 609 | 599.24 | 12,469 | 2,434 | 1,603 | 1,388 | Upgrade
|
| Operating Expenses | 111,093 | 111,741 | 114,298 | 87,598 | 82,324 | 79,563 | Upgrade
|
| Operating Income | 4,921 | 2,624 | -24,955 | 8,312 | 15,758 | 19,705 | Upgrade
|
| Interest Expense | -2,122 | -2,159 | -1,596 | -867.87 | -65.82 | -1,234 | Upgrade
|
| Interest & Investment Income | 2,791 | 2,518 | 3,170 | 2,702 | 2,610 | 2,769 | Upgrade
|
| Earnings From Equity Investments | 283.13 | 503.27 | 3,083 | 11,387 | -155.57 | -100.42 | Upgrade
|
| Currency Exchange Gain (Loss) | 274.72 | 266.84 | -5.73 | -40.15 | 161.08 | -377.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -516.53 | -192.72 | -410.62 | -1,701 | -736.18 | -1,350 | Upgrade
|
| EBT Excluding Unusual Items | 5,632 | 3,561 | -20,714 | 19,792 | 17,572 | 19,412 | Upgrade
|
| Gain (Loss) on Sale of Investments | 379.47 | 1,765 | 2,149 | -1,709 | 786.97 | -97.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | -91.2 | 92.39 | 61.03 | -142.27 | 73.23 | 24.37 | Upgrade
|
| Asset Writedown | -197.41 | -197.41 | - | - | - | - | Upgrade
|
| Pretax Income | 5,722 | 5,221 | -18,503 | 17,941 | 18,432 | 19,339 | Upgrade
|
| Income Tax Expense | -63.8 | -226.72 | 2,227 | 5,828 | 5,806 | 6,467 | Upgrade
|
| Earnings From Continuing Operations | 5,786 | 5,448 | -20,730 | 12,113 | 12,627 | 12,873 | Upgrade
|
| Minority Interest in Earnings | 28.65 | 21.86 | 22.77 | 48.4 | 45.13 | -413.43 | Upgrade
|
| Net Income | 5,815 | 5,470 | -20,708 | 12,161 | 12,672 | 12,459 | Upgrade
|
| Net Income to Common | 5,815 | 5,470 | -20,708 | 12,161 | 12,672 | 12,459 | Upgrade
|
| Net Income Growth | - | - | - | -4.03% | 1.71% | -38.09% | Upgrade
|
| Shares Outstanding (Basic) | 27 | 27 | 27 | 27 | 28 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 28 | 25 | Upgrade
|
| Shares Change (YoY) | -0.66% | -0.57% | -0.27% | -1.14% | 12.18% | 3.62% | Upgrade
|
| EPS (Basic) | 215.82 | 202.73 | -763.17 | 446.96 | 460.42 | 507.81 | Upgrade
|
| EPS (Diluted) | 215.82 | 202.73 | -763.17 | 446.96 | 460.42 | 507.81 | Upgrade
|
| EPS Growth | - | - | - | -2.92% | -9.33% | -40.26% | Upgrade
|
| Free Cash Flow | 4,205 | -15,692 | -6,322 | -11,649 | 8,496 | -11,475 | Upgrade
|
| Free Cash Flow Per Share | 156.07 | -581.60 | -232.98 | -428.12 | 308.70 | -467.69 | Upgrade
|
| Dividend Per Share | 300.000 | 300.000 | - | 400.000 | 500.000 | 500.000 | Upgrade
|
| Dividend Growth | - | - | - | -20.00% | - | 25.00% | Upgrade
|
| Gross Margin | 59.60% | 58.97% | 54.92% | 52.49% | 55.22% | 57.11% | Upgrade
|
| Operating Margin | 2.53% | 1.35% | -15.34% | 4.55% | 8.87% | 11.34% | Upgrade
|
| Profit Margin | 2.99% | 2.82% | -12.73% | 6.66% | 7.13% | 7.17% | Upgrade
|
| Free Cash Flow Margin | 2.16% | -8.09% | -3.89% | -6.38% | 4.78% | -6.60% | Upgrade
|
| EBITDA | 9,853 | 8,044 | -19,106 | 15,016 | 22,770 | 26,479 | Upgrade
|
| EBITDA Margin | 5.06% | 4.15% | -11.74% | 8.22% | 12.82% | 15.23% | Upgrade
|
| D&A For EBITDA | 4,932 | 5,420 | 5,849 | 6,704 | 7,011 | 6,774 | Upgrade
|
| EBIT | 4,921 | 2,624 | -24,955 | 8,312 | 15,758 | 19,705 | Upgrade
|
| EBIT Margin | 2.53% | 1.35% | -15.34% | 4.55% | 8.87% | 11.34% | Upgrade
|
| Effective Tax Rate | - | - | - | 32.49% | 31.50% | 33.44% | Upgrade
|
| Advertising Expenses | - | 5,857 | 5,248 | 10,315 | 9,603 | 10,510 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.